These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30897345)

  • 1. Rosiglitazone-dependent dissociation of HuR from PPAR-γ regulates adiponectin expression at the posttranscriptional level.
    Hwang JS; Lee WJ; Hur J; Lee HG; Kim E; Lee GH; Choi MJ; Lim DS; Paek KS; Seo HG
    FASEB J; 2019 Jun; 33(6):7707-7720. PubMed ID: 30897345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saturated fatty acids induce post-transcriptional regulation of HAMP mRNA via AU-rich element-binding protein, human antigen R (HuR).
    Lu S; Mott JL; Harrison-Findik DD
    J Biol Chem; 2015 Oct; 290(40):24178-89. PubMed ID: 26304124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone Elicits an Adiponectin-Mediated Insulin-Sensitizing Action at the Adipose Tissue-Liver Axis in Otsuka Long-Evans Tokushima Fatty Rats.
    Li J; Xue YM; Zhu B; Pan YH; Zhang Y; Wang C; Li Y
    J Diabetes Res; 2018; 2018():4627842. PubMed ID: 30225267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-4-induced posttranscriptional gene regulation of CCL26 by the RNA-binding protein HuR in primary human nasal polyp-derived epithelial cells.
    Tian P; Ou H; Wu F; Ma Y; Liu X; Chen Q; Dang H; Zou H
    Int Forum Allergy Rhinol; 2019 Mar; 9(3):311-321. PubMed ID: 30472791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosiglitazone inhibits monocyte/macrophage adhesion through de novo adiponectin production in human monocytes.
    Tsai JS; Chen CY; Chen YL; Chuang LM
    J Cell Biochem; 2010 Aug; 110(6):1410-9. PubMed ID: 20506517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of rosiglitazone on peroxisome proliferator activated receptor-γ pathway in patients with chronic obstructive pulmonary disease].
    Zeng XL; Liu XJ; Bao HR; Zhang Y; Tan EL; Liao JM
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Oct; 34(10):743-8. PubMed ID: 22321707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone Suppresses Calcium Oxalate Crystal Binding and Oxalate-Induced Oxidative Stress in Renal Epithelial Cells by Promoting PPAR-
    Liu YD; Yu SL; Wang R; Liu JN; Jin YS; Li YF; An RH
    Oxid Med Cell Longev; 2019; 2019():4826525. PubMed ID: 31781338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA Binding Protein, HuR, Regulates
    Zhou A; Shi G; Kang GJ; Xie A; Liu H; Jiang N; Liu M; Jeong EM; Dudley SC
    J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29678826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGFBP-3, hypoxia and TNF-alpha inhibit adiponectin transcription.
    Zappalà G; Rechler MM
    Biochem Biophys Res Commun; 2009 May; 382(4):785-9. PubMed ID: 19324019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of adiponectin receptors in hepatocytes by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Sun X; Han R; Wang Z; Chen Y
    Diabetologia; 2006 Jun; 49(6):1303-10. PubMed ID: 16609881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination.
    Tsuchida A; Yamauchi T; Takekawa S; Hada Y; Ito Y; Maki T; Kadowaki T
    Diabetes; 2005 Dec; 54(12):3358-70. PubMed ID: 16306350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydrotanshinone-I interferes with the RNA-binding activity of HuR affecting its post-transcriptional function.
    D'Agostino VG; Lal P; Mantelli B; Tiedje C; Zucal C; Thongon N; Gaestel M; Latorre E; Marinelli L; Seneci P; Amadio M; Provenzani A
    Sci Rep; 2015 Nov; 5():16478. PubMed ID: 26553968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttranscriptional Regulation of the Inflammatory Marker C-Reactive Protein by the RNA-Binding Protein HuR and MicroRNA 637.
    Kim Y; Noren Hooten N; Dluzen DF; Martindale JL; Gorospe M; Evans MK
    Mol Cell Biol; 2015 Dec; 35(24):4212-21. PubMed ID: 26438598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C alpha-dependent phosphorylation of the mRNA-stabilizing factor HuR: implications for posttranscriptional regulation of cyclooxygenase-2.
    Doller A; Huwiler A; Müller R; Radeke HH; Pfeilschifter J; Eberhardt W
    Mol Biol Cell; 2007 Jun; 18(6):2137-48. PubMed ID: 17392515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPAR-γ activation by rosiglitazone suppresses angiotensin II-mediated proliferation and phenotypictransition in cardiac fibroblasts via inhibition of activation of activator protein 1.
    Hou X; Zhang Y; Shen YH; Liu T; Song S; Cui L; Bu P
    Eur J Pharmacol; 2013 Sep; 715(1-3):196-203. PubMed ID: 23791613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The peroxisome proliferator-activated receptor agonist rosiglitazone specifically represses tumour metastatic potential in chromatin inaccessibility-mediated FABP4-deficient gastric cancer.
    Chen QY; Huang XB; Zhao YJ; Wang HG; Wang JB; Liu LC; Wang LQ; Zhong Q; Xie JW; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Zheng CH; Li P; Huang CM
    Theranostics; 2022; 12(4):1904-1920. PubMed ID: 35198079
    [No Abstract]   [Full Text] [Related]  

  • 17. Adiponectin expression is induced by vitamin E via a peroxisome proliferator-activated receptor gamma-dependent mechanism.
    Landrier JF; Gouranton E; El Yazidi C; Malezet C; Balaguer P; Borel P; Amiot MJ
    Endocrinology; 2009 Dec; 150(12):5318-25. PubMed ID: 19833717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral intake of rosiglitazone promotes a central antihypertensive effect via upregulation of peroxisome proliferator-activated receptor-gamma and alleviation of oxidative stress in rostral ventrolateral medulla of spontaneously hypertensive rats.
    Chan SH; Wu KL; Kung PS; Chan JY
    Hypertension; 2010 Jun; 55(6):1444-53. PubMed ID: 20404217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
    Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
    Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PARP1 promotes gene expression at the post-transcriptiona level by modulating the RNA-binding protein HuR.
    Ke Y; Han Y; Guo X; Wen J; Wang K; Jiang X; Tian X; Ba X; Boldogh I; Zeng X
    Nat Commun; 2017 Mar; 8():14632. PubMed ID: 28272405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.